Citations

Citations to this article as recorded by  

• A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics
  Menghan Zhang, Qi Wang, Gongming Zhang, Guangming Li, Ronghua Jin, Huichun Xing
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Feasibility of an artificial intelligence system for tumor response evaluation
  Nie Xiuli, Chen Hua, Gao Peng, Yu Hairong, Sun Meili, Yan Peng
  BMC Medical Imaging.2024;[Epub]     CrossRef
• Immunotherapy Assessment: A New Paradigm for Radiologists
  Vincenza Granata, Roberta Fusco, Sergio Venanzio Setola, Igino Simonetti, Carmine Picone, Ester Simeone, Lucia Festino, Vito Vanella, Maria Grazia Vitale, Agnese Montanino, Alessandro Morabito, Francesco Izzo, Paolo Antonio Ascierto, Antonella Petrillo
  Diagnostics.2023; 13(2): 302.     CrossRef
• Study on the Application Value of Lung-RADS in the Differential Diagnosis of Benign and Malignant Lung Nodules
  ·马木提 依力夏提
  Advances in Clinical Medicine.2023; 13(12): 20190.     CrossRef
• Reliability and accuracy in radiographic measurements of musculoskeletal tumors
  Alec S. Kellish, Sandra Miskiel, John Gaughan, Veniamin Barshay, Tae W. Kim, Christina J. Gutowski
  Journal of Orthopaedic Research.2022; 40(7): 1654.     CrossRef
• Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance
  Anyue Yin, Johan G. C. van Hasselt, Henk-Jan Guchelaar, Lena E. Friberg, Dirk Jan A. R. Moes
  Scientific Reports.2022;[Epub]     CrossRef
• Correlation Between Early Time-to-Event Outcomes and Overall Survival in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiation Therapy: Systematic Review and Meta-Analysis
  Christopher M. Black, Sam Keeping, Ali Mojebi, Karthik Ramakrishnan, Diana Chirovsky, Navneet Upadhyay, Dylan Maciel, Dieter Ayers
  Frontiers in Oncology.2022;[Epub]     CrossRef
• A quantitative and comparative evaluation of stereotactic spine radiosurgery local control: proposing a consistent measurement methodology
  Ran Harel, Tehila Kaisman-Elbaz, Todd Emch, Paul Elson, Samuel T Chao, John H Suh, Lilyana Angelov
  Neurosurgical Focus.2022; 53(5): E10.     CrossRef
• Lung-RADS Version 1.1: Challenges and a Look Ahead, From the AJR Special Series on Radiology Reporting and Data Systems
  Lydia Chelala, Rydhwana Hossain, Ella A. Kazerooni, Jared D. Christensen, Debra S. Dyer, Charles S. White
  American Journal of Roentgenology.2021; 216(6): 1411.     CrossRef
• Perillyl alcohol as a treatment for cancer: A systematic review
  Aimée Obolari Durço, Lino Sérgio Rocha Conceição, Diego Santos de Souza, Carlos Anselmo Lima, Jullyana de Souza Siqueira Quintans, Márcio Roberto Viana dos Santos
  Phytomedicine Plus.2021; 1(3): 100090.     CrossRef
• Neoadjuvant Chemotherapy for Advanced Gallbladder Cancer: Do We have Enough Evidence? A Systematic Review
  Shah Naveed, Hasina Qari, Cao M Thau, Pipit Burasakarn, Abdul W Mir
  Euroasian Journal of Hepato-Gastroenterology.2021; 11(2): 87.     CrossRef
• Objective response rate assessment in oncology: Current situation and future expectations
  Nuri Faruk Aykan, Tahsin Özatlı
  World Journal of Clinical Oncology.2020; 11(2): 53.     CrossRef
• Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma
  Omar Abdel-Rahman, Zeinab Elsayed
  Cochrane Database of Systematic Reviews.2020;[Epub]     CrossRef
• What scans we will read: imaging instrumentation trends in clinical oncology
  Thomas Beyer, Luc Bidaut, John Dickson, Marc Kachelriess, Fabian Kiessling, Rainer Leitgeb, Jingfei Ma, Lalith Kumar Shiyam Sundar, Benjamin Theek, Osama Mawlawi
  Cancer Imaging.2020;[Epub]     CrossRef
• Herb–drug interactions between the medicinal mushrooms Lingzhi and Yunzhi and cytotoxic anticancer drugs: a systematic review
  Chun Sing Lam, Lok Pui Cheng, Li Min Zhou, Yin Ting Cheung, Zhong Zuo
  Chinese Medicine.2020;[Epub]     CrossRef
• Immune Response Evaluation and Treatment with Immune Checkpoint Inhibitors Beyond Clinical Progression: Response Assessments for Cancer Immunotherapy
  Sirisha L. Mushti, Flora Mulkey, Shenghui Tang, Harpreet Singh, Steven J. Lemery, Kirsten B. Goldberg, Rajeshwari Sridhara, Patricia Keegan, Paul G. Kluetz, Richard Pazdur, Marc R. Theoret, Julia A. Beaver
  Current Oncology Reports.2020;[Epub]     CrossRef
• Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma
  Yoko Tomita, Max Moldovan, Rachael Chang Lee, Amy HC Hsieh, Amanda Townsend, Timothy Price
  Cochrane Database of Systematic Reviews.2020;[Epub]     CrossRef
• The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer – A systematic review
  Abdul R Hakeem, Michail Papoulas, Krishna V Menon
  European Journal of Surgical Oncology.2019; 45(2): 83.     CrossRef
• Polymorphisms of genes encoding drug transporters or cytochrome P450 enzymes and association with clinical response in cancer patients: a systematic review
  Inthuorn Kulma, Kanyarat Boonprasert, Kesara Na-Bangchang
  Cancer Chemotherapy and Pharmacology.2019; 84(5): 959.     CrossRef
• Identification of a 13‑gene‑based classifier as a potential biomarker to predict the effects of fluorouracil‑based chemotherapy in colorectal cancer
  Zuhuan Gan, Qiyuan Zou, Yan Lin, Zihai Xu, Zhong Huang, Zhichao Chen, Yufeng Lv
  Oncology Letters.2019;[Epub]     CrossRef
• Tumor Response Assessment for Precision Cancer Therapy: Response Evaluation Criteria in Solid Tumors and Beyond
  Mizuki Nishino
  American Society of Clinical Oncology Educational Book.2018; (38): 1019.     CrossRef
• Practical clinical guide on the use of talimogene laherparepvec monotherapy in patients with unresectable melanoma in Europe
  Ralf Gutzmer, Kevin J. Harrington, Christoph Hoeller, Celeste Lebbé, Josep Malvehy, Katarina Öhrling, Gerald Downey, Reinhard Dummer
  European Journal of Dermatology.2018; 28(6): 736.     CrossRef
• Unidimensional measurement may be superior to assess primary tumor response after neoadjuvant chemotherapy for nasopharyngeal carcinoma
  Chuanben Chen, Xiurong Lin, Yuanji Xu, Penggang Bai, Youping Xiao, Yuhui Pan, Chao Li, Zhizhong Lin, Mingwei Zhang, Yunbin Chen
  Oncotarget.2017; 8(29): 46937.     CrossRef
• Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?
  Toru Mizuguchi, Toshihiko Torigoe, Fukino Satomi, Hiroaki Shima, Goro Kutomi, Shigenori Ota, Masayuki Ishii, Hiroshi Hayashi, Sumiyo Asakura, Yoshihiko Hirohashi, Makoto Meguro, Yasutoshi Kimura, Toshihiko Nishidate, Kenji Okita, Masaho Ishino, Atsushi Mi
  Surgery Today.2016; 46(2): 139.     CrossRef
• Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors
  Mustafa Aras, Tanju Y. Erdil, Faysal Dane, Serkan Gungor, Tunc Ones, Fuat Dede, Sabahat Inanir, Halil T. Turoglu
  Nuclear Medicine Communications.2016; 37(1): 9.     CrossRef
• Recommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review
  Luca G. Campana, A. James P. Clover, Sara Valpione, Pietro Quaglino, Julie Gehl, Christian Kunte, Marko Snoj, Maja Cemazar, Carlo R. Rossi, Damijan Miklavcic, Gregor Sersa
  Radiology and Oncology.2016; 50(1): 1.     CrossRef
• Comparison of the RECIST 1.0 and RECIST 1.1 in patients treated with targeted agents: a pooled analysis and review
  Jung Han Kim
  Oncotarget.2016; 7(12): 13680.     CrossRef
• Assessment of Treatment Response Using PET
  Sandip Basu, Rakesh Kumar, Rohit Ranade
  PET Clinics.2015; 10(1): 9.     CrossRef
• Single-Lesion Measurement per Organ for Assessing Tumor Response in Advanced Gastric Cancer
  Hyeong Su Kim, Ji Won Kim, Jung Han Kim, Dae Ro Choi, A. Rum Han, Min-Joeng Kim, Byung Chun Kim, Dae Young Zang
  Oncology.2015; 88(2): 69.     CrossRef
• Tumor response assessment by measuring the single largest lesion per organ in patients with advanced non-small cell lung cancer
  Hyeong Su Kim, Jung Han Kim, Ik Yang
  Lung Cancer.2014; 85(3): 385.     CrossRef
• Nucleotide excision repair gene polymorphisms and prognosis of non-small cell lung cancer patients receiving platinum-based chemotherapy: A meta-analysis based on 44 studies
  DONGNING HUANG, YANG ZHOU
  Biomedical Reports.2014; 2(4): 452.     CrossRef
• XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis
  Fanghui Ye, Zhenfang Liu, Aihua Tan, Ming Liao, Zengnan Mo, Xiaobo Yang
  Cancer Chemotherapy and Pharmacology.2013; 71(3): 733.     CrossRef
• Relationship between 6‐ and 9‐month progression‐free survival and overall survival in patients with metastatic urothelial cancer treated with first‐line cisplatin‐based chemotherapy
  Matthew D. Galsky, Susan Krege, Chia‐Chi Lin, Noah Hahn, Thorsten Ecke, Erin Moshier, Guru Sonpavde, James Godbold, William K. Oh, Aristotle Bamias
  Cancer.2013; 119(16): 3020.     CrossRef
• Diagnostic and therapeutic imaging for cancer: Therapeutic considerations and future directions
  Mack Roach, Jean‐Louis Alberini, Alain Paul Pecking, Alessandro Testori, Francesco Verrecchia, Javier Soteldo, Ute Ganswindt, John L. Joyal, John W. Babich, Russell S. Witte, Evan Unger, Ronald Gottlieb
  Journal of Surgical Oncology.2011; 103(6): 587.     CrossRef